Skip to main content

Corcept Therapeutics Inc

CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001088856

In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.

Members of Congress who traded CORT

No member of Congress has reported a trade in Corcept Therapeutics Inc since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.